LAURA KREMER: Open Payments
NPI 1376055723 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 5 payments from 5 companies in 2025. Trend: 2023 $644 · 2024 $361 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $122 |
| Eisai Inc. | 1 | $121 |
| Medtronic, Inc. | 1 | $112 |
| Neurocrine BioSciences, Inc. | 1 | $49 |
| Dexcom, Inc. | 1 | $35 |
Products named: Epclusa, Leqembi, INTERSTIM, INGREZZA, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
